MENU
PHGE
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
BiomX (PHGE) Ownership - Who owns BiomX?
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis... Show more
Profile
Industry
N/A
Address
22 Einstein Street
Phone
+972 723942377
Employees
71
Web
https://www.biomx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.83M
P/E Ratio
0.02
Total Cash
23.54M
Projected Growth
N/A
Total Debt
9.75M
Revenue
N/A
Risk (Beta)
1.98
Dividend Yield
N/A
Total Cash/Share
0.90
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PHGE
Capitalization
12.8M
P/E Ratio
0.02
Risk (Beta)
1.98
Dividend Yield
N/A
Total Cash
23.5M
Total Cash/Share
0.90
Total Debt
9.75M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
19.3M
P/B Ratio
2.19
Cash Flow
N/A
Earnings
-1.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
3.17
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-5.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-18.71
Shares Held By Institutions
7.24M
Shares Outstanding - Current
26.2M
Total Liabilities
22.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-31.516
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
22 Einstein Street
Phone
+972 723942377
Employees
71
Web
https://www.biomx.com